Filing Flows › Verastem (VSTM) › Q2 2026 › vs Q1 2026
Verastem (VSTM) Q2 2026 vs Q1 2026 (quarter over quarter)
Verastem's revenue rose $21.4M (+115%) from $18.7M in Q1 2026 to $40.1M in Q2 2026.
Verastem, Q2 2026: revenue $40.1M (19× year over year), operating margin -81.6%, net loss $34.7M, operating cash flow −$43.9M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $40.1M | $18.7M | $21.4M | +115% |
| Net loss | $34.7M | $36.6M | −$1.9M | -5% |
| Costs & expenses | $74.8M | $63.6M | $11.2M | +18% |
| Operating costs | $72.8M | $63.6M | $9.2M | +15% |
| Interest & other, net | $1.1M | −$8.3M | $9.5M | — |
| Income tax | $816K | $0 | $816K | — |
| Research & development | $41.3M | $38.2M | $3.1M | +8% |
| SG&A | $27.4M | $22.3M | $5.1M | +23% |
| Other operating costs | $4.0M | $3.1M | $990K | +32% |
| Operating cash sources | $47.3M | $54.2M | −$6.8M | -13% |
| Share-based compensation | $3.4M | $2.0M | $1.4M | +68% |
| Cash used in operations | $43.9M | $52.1M | −$8.2M | -16% |
| Net loss absorbed | $34.7M | $36.6M | −$1.9M | -5% |
| Working capital & other | $12.7M | $17.6M | −$4.9M | -28% |
Questions
How much did Verastem's revenue grow quarter over quarter in Q2 2026?
Verastem's revenue rose $21.4M (+115%) from $18.7M in Q1 2026 to $40.1M in Q2 2026.